on 21 Jun 2024
Last Applicant/ Owned by
2SEVENTY BIO INC.
60 Binney StreetCambridge MA 02142
US
Serial Number
2197937 filed on 01st Jun 2022
Registration Number
TMA1239708 registered on 21st Jun 2024
Registration expiry Date
01st Jun 2032Correspondent Address
SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO
ONTARIO
CA
M5X1G5
7
Vienna Information
24 . 15 . 21
Arrowheads -- Note: Not including arrowheads in the form of angles (26.3.23).Pointes de flèches -- Note: Non compris les pointes de flèches en forme d'angles (26.3.23).
25 . 5 . 3
Backgrounds divided into two, diagonallyFonds partagés en deux en oblique
26 . 3 . 23
Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.
26 . 11 . 1
One line or one bandUne ligne ou une bande
27 . 7 . 1
Numerals presenting a special form of writingChiffres présentant un graphisme spécial
27 . 7 . 11
Numerals juxtaposed or joined to a letter or a figurative elementChiffres juxtaposés ou accolés à une lettre ou à un élément figuratif
27 . 7 . 21
One numeralUn chiffre
29 . 1 . 3
GreenVert
Trademark usage description
pharmaceutical preparations and substances for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases Read MoreClassification Information
Class [005]
Pharmaceutical preparations and substances for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases namely, respiratory infections, blood infections, skin infections, urinary tract infections, bowel infections, and eye infections, autoimmune diseases, and cancer; genetically modified cells namely, pharmaceutical preparations for use in cell therapy, biological preparations made from human blood cells for the treatment of cancer, and biological preparations made from human blood cells for use in T-cell immunotherapy, reagents for DNA editing and modification, and viral vectors, namely retroviral vectors, lentiviral vectors, adenoviral vectors, and adeno-associated viral vectors, for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases namely, respiratory infections, blood infections, skin infections, urinary tract infections, bowel infections, and eye infections, autoimmune diseases, and cancer
Classification kind code
11
Class [042]
Pharmaceutical research and development.
Classification kind code
11
Mark Details
Serial Number
2197937
Mark Type
Trademark
Legal History
| Action Taken | Status |
|---|---|
| Submitted for opposition 22 on 20th Jul 2023 | Search Recorded |
| Submitted for opposition 20 on 20th Jul 2023 | Examiner's First Report |
| Submitted for opposition 223 on 20th Jul 2023 | Total Provisional Refusal |
| Submitted for opposition 256 on 15th May 2023 | Notification of Possible Opposition Sent |
| Submitted for opposition 48 on 29th Jul 2022 | Agent Changed |
| Submitted for opposition 257 on 14th Jul 2022 | Designation Notification - Madrid Protocol |
| Submitted for opposition 31 on 13th Jul 2022 | Formalized |
| Submitted for opposition 1 on 13th Jul 2022 | Created |
| Submitted for opposition 228 on 01st Jun 2022 | International Registration |
| Submitted for opposition 30 on 01st Jun 2022 | Filed |